Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Novel antiinfective agents disclosed in recent patent literature

Aug. 22, 2006

Novel treatment options for metabolic disorders described in recent Merck and Dainippon patents

Aug. 22, 2006

Novel agents for treating neurological disorders disclosed in recent patent literature

Aug. 22, 2006

Recent Tibotec and Pfizer patents report novel therapeutic agents for HIV infection

Aug. 21, 2006

Recent Tanabe and Dainippon patents describe new antidiabetic agents

Aug. 21, 2006

Recent Tanabe and Neurogen patents report novel analgesic agents

Aug. 21, 2006

New imaging agents for ocular disorders and cancer disclosed in recent GE and Yeda patents

Aug. 21, 2006

Recent Universitaetsklinikum Muenster patent discloses novel diagnostic agents

Aug. 17, 2006

Recent patents describe novel agents for anxiety, depression, psychosis etc.

Aug. 17, 2006

Recent patents describe new analgesic agents

Aug. 17, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.